Animal Nutrients | Market Size, Share & Growth Report 2025-2033
The Animal Nutrients Market Report is Segmented by Product Type (Vitamins, Minerals, Amino Acids, Enzymes, and Proteins), Application (Feed Additives, Pharmaceuticals, Veterinary Diets, Pet Food, and Others), Distribution Channel (Online Stores, Veterinary Clinics, Pet Specialty Stores, Farm Supply Stores, and Others), Ingredient Type (Probiotics, Prebiotics, Omega-3 Fatty Acids, Antioxidants, and Growth Promoters).
Animal Nutrients Market
Market Analysis
How the market stands today, and what is shaping it
The global animal nutrients market was estimated at approximately USD 32.0 billion in 2025 and is projected to reach around USD 47.64 billion by 2033, representing a CAGR of approximately 5.10% during 2025-2033, based on Core Market Research estimates. The market covers amino acids led by methionine and lysine, vitamins, minerals, feed enzymes and nutritional proteins, together with the probiotics, prebiotics, antioxidants and omega-3 sources formulated alongside them. Growth rests on synthetic amino acids that let a formulator meet a specific requirement without over-supplying protein, on fermentation capacity at a scale that changes least-cost calculations, and on restrictions that moved rations towards probiotics, prebiotics and enzymes. Expansion is limited by amino acid capacity running ahead of demand, by vitamin supply concentrated in a handful of plants, and by livestock numbers growing slowly in mature markets. Competition divides by category rather than by company size, with Evonik Industries AG and CJ CheilJedang Corporation in commodity amino acids and Novonesis in technology-led enzymes. The agreed divestment of a business carrying about EUR 3.5 billion of annual net sales to CVC Capital Partners at roughly EUR 2.2 billion enterprise value is the clearest current signal of how these earnings are valued.
Market Dynamics
Key market dynamics and their impact on the industry landscape
Market Drivers
- Synthetic amino acids let a formulator meet an animal's requirement for a specific amino acid without over-supplying total protein, which reduces both feed cost and nitrogen excretion. Amino acids accordingly held a 19.5 percent share of feed additive revenue in 2025, the largest single product category in the market.
- Fermentation and chemical synthesis have brought nutrient production to a scale that changes formulation economics. Evonik Industries AG holds more than 700,000 tonnes of annual MetAMINO capacity and CJ CheilJedang Corporation 520,000 tonnes of lysine capacity, volumes at which a least-cost model can substitute supplemental amino acids for intact protein.
- Restrictions on antibiotic growth promoters, applied first in the European Union, removed a tool that producers had to replace. Probiotics, prebiotics and enzymes expanded into that space, and the regulatory decision rather than any nutritional discovery is what created the commercial opening those categories now occupy.
- Nutrients are specified by least-cost formulation software, so a product enters a ration when its contribution to a nutrient requirement costs less than the alternative. That makes adoption a calculation rather than a preference, which is why synthetic sources accounted for 73.9 percent of feed additive supply in 2025.
- Capacity is being added ahead of demand by the largest producers. Leading amino acid manufacturers collectively added 340,000 tonnes of annual production since 2023, and Evonik Industries AG completed a 40,000 tonne expansion in Singapore that brought the site to 340,000 tonnes a year.
Market Challenges
- Amino acids are commodities whose price falls towards cash cost when capacity runs ahead of demand. Leading manufacturers added 340,000 tonnes of annual capacity since 2023, and CJ CheilJedang Corporation recorded lysine revenues of only USD 269 million in 2025 against a 9.6 percent share of that market.
- The industry's largest portfolio changed hands rather than grew. dsm-firmenich agreed to divest an Animal Nutrition and Health business carrying about EUR 3.5 billion of annual net sales at an enterprise value of approximately EUR 2.2 billion, a valuation below one times sales for a nutrition business.
- Vitamin supply depends on a small number of plants worldwide, so a single site outage moves global prices in a way that no amount of contracting by feed mills can hedge. That concentration is a structural feature of the chemistry rather than a consequence of recent consolidation.
- Nutrient demand tracks livestock numbers, which are growing slowly in mature markets. North American premix and additive use is already near universal in commercial production, so suppliers there compete for share of an existing ration rather than for new adoption.
- Omega-3 supply for animal nutrition competes against human supplement demand for the same marine and algal sources. Animal rations are formulated to least cost and rarely outbid a human supplement market for the same oil, which caps how far the ingredient penetrates livestock feed.
Opportunities
- Latin American feed production reached 204.446 million tonnes across all species in 2025 while most amino acid supply is imported from Asian and European plants. Regional fermentation capacity could serve Brazilian poultry and swine formulators without the freight and currency exposure that imported nutrients carry.
- African feed production grew 11.5 percent in 2025, the fastest regional rate in Alltech's survey, from a base where premix and additive penetration is lower than in mature markets. Nutrient suppliers could capture both volume growth and rising inclusion rates in the same market rather than one or the other.
- Enzyme technology is the least commoditised category in animal nutrition, which is why Novonesis paid EUR 1.5 billion for dsm-firmenich's feed enzyme activities in 2025. Further enzyme development may allow nutrient suppliers to escape the price competition that amino acid capacity additions have created.
- Producers of amino acids, vitamins and enzymes can direct output between animal and human markets at different purity grades. Expanding the pharmaceutical and human nutrition share of a plant's output could stabilise returns when feed demand softens, and may justify capacity that livestock nutrition alone would not.
Trends and Insights
Key market trends shaping the industry landscape
Ownership is moving to financial buyers
High impactShort-termLarge chemical and nutrition groups are selling animal nutrition portfolios to private capital rather than expanding them.
Insight: dsm-firmenich agreed to divest its Animal Nutrition and Health business, about EUR 3.5 billion of annual net sales, to CVC Capital Partners at roughly EUR 2.2 billion enterprise value while keeping a 20 percent stake. A diversified group judged the business a better fit outside its portfolio than within it.
Amino acid capacity is outrunning demand
High impactMid-termProduction capacity in the largest nutrient category is being added faster than feed tonnage is growing.
Insight: Leading manufacturers added 340,000 tonnes of annual amino acid capacity since 2023, and CJ CheilJedang Corporation recorded lysine revenues of USD 269 million in 2025 against a 9.6 percent market share. Prices in a commodity nutrient converge on cash cost when supply leads demand.
Enzymes are consolidating with biotechnology
Medium impactMid-termFeed enzyme assets are moving towards companies whose core capability is industrial fermentation rather than animal nutrition.
Insight: Novonesis acquired dsm-firmenich's feed enzyme activities for EUR 1.5 billion in 2025, placing them alongside enzymes developed for detergents, baking and biofuel. Shared fermentation and strain development platforms matter more to enzyme economics than proximity to a feed mill does.
Supply is relocating into consuming regions
Medium impactLong-termNutrient manufacturers are building capacity inside the regions that consume the output rather than exporting to them.
Insight: Evonik Industries AG expanded Singapore DL-methionine capacity by 40,000 tonnes to 340,000 tonnes a year, serving an Asia Pacific region holding 35.0 percent of global feed additive revenue, while CJ CheilJedang Corporation built lysine production in Iowa for the North American corn belt.
Regulation keeps redefining the category
Medium impactLong-termRestrictions on one class of additive are repeatedly creating the commercial opening for another.
Insight: European Union limits on antibiotic growth promoters moved formulation towards probiotics, prebiotics and enzymes, and synthetic sources still supplied 73.9 percent of feed additives in 2025. The product mix in a ration reflects what regulators have permitted as much as what nutritionists would choose.
Segment Analysis
Market segmentation by product type, application, distribution channel, ingredient type
Amino acids are the largest product category by revenue, holding a 19.5 percent share of feed additive revenue in 2025, and they are also the most commoditised. Methionine and lysine dominate that category, with Evonik Industries AG holding more than 700,000 tonnes of annual MetAMINO capacity and CJ CheilJedang Corporation 520,000 tonnes of lysine capacity. Vitamins are produced by a small number of plants worldwide, which makes their pricing unusually sensitive to single-site outages. Enzymes form the most technology-intensive category, and Novonesis acquired dsm-firmenich's feed enzyme activities for EUR 1.5 billion in 2025 on that basis. Minerals are the lowest-value category per tonne, and nutritional proteins overlap with the feed ingredients they are blended into rather than forming a separate cohort.
Geography Analysis
Regional market analysis
Asia Pacific
Asia Pacific took 35.0% of global feed additive revenue in 2025, the largest regional share, driven by Chinese and Southeast Asian poultry, swine and aquaculture production. Regional market revenue grew during 2025 as synthetic sources supplied 73.9% of feed additives and leading manufacturers added 340,000 tonnes a year of amino acid capacity since 2023. Evonik Industries AG expanded its Singapore DL-methionine plant by 40,000 tonnes to 340,000 tonnes annually, placing a substantial share of global methionine supply inside the region it serves. CJ CheilJedang Corporation of South Korea operates 520,000 tonnes of lysine capacity globally, and Ajinomoto Co., Inc. of Japan holds a long-established amino acid position.
North America
North America is a mature animal nutrition market where volume growth tracks livestock numbers rather than penetration, since premix and additive use is already near universal in commercial production. Cargill, Incorporated operates animal nutrition production and premix blending across the region alongside its compound feed business. CJ CheilJedang Corporation built lysine production in Iowa to serve the corn belt swine and poultry sectors from inside the region. Regulatory treatment of growth promoters here has historically been less restrictive than in the European Union, which left a slower transition towards probiotics, prebiotics and enzymes than European producers made.
Latin America
Brazil is the region's centre of demand, with poultry and swine production at export scale drawing substantial amino acid and enzyme volume, and Argentina and Mexico following. Regional feed production of 204.446 million tonnes across all species in 2025 gives nutrient suppliers a large and expanding outlet. Most amino acid supply is imported from Asian and European plants rather than produced locally, which exposes Brazilian feed millers to freight and currency movements on an input with few local substitutes. No regional revenue series specific to animal nutrients was identified from a government statistical agency.
Europe
Europe is where the industry's ownership has changed most, rather than where its volume is growing. dsm-firmenich agreed to divest its Animal Nutrition and Health business to CVC Capital Partners at an enterprise value of approximately EUR 2.2 billion, retaining a 20 percent stake. That segment carried about EUR 3.5 billion of annual net sales, a divisional figure rather than a group total, and the company had already sold feed enzyme activities to Novonesis for EUR 1.5 billion. Evonik Industries AG has produced methionine at Antwerp for more than 50 years as of October 2024. European restrictions on antibiotic growth promoters moved formulation towards probiotics, prebiotics and enzymes earlier than in other regions.
Middle East & Africa
The region imports nearly all of its animal nutrients, since no amino acid, vitamin or enzyme production at the scale of the Singapore, Antwerp or Iowa plants has been identified within it. Gulf poultry and dairy operations are the identifiable commercial buyers, formulating to specifications comparable to European and North American practice. African feed production grew 11.5 percent in 2025, the fastest regional rate recorded in Alltech's survey, which expands the base into which nutrients are sold. No government agency in the region publishes animal nutrient revenue or consumption data that would support a regional market figure.
Competitive Landscape
Key players and market positioning analysis
Animal nutrients divide into categories with sharply different competitive characteristics, and a company's position depends more on which categories it holds than on its overall size. Amino acids are the largest category by revenue at a 19.5 percent share of feed additives in 2025, and the most commoditised. Evonik Industries AG leads there with more than 700,000 tonnes of annual MetAMINO capacity, after a 40,000 tonne Singapore expansion took that site to 340,000 tonnes. CJ CheilJedang Corporation competes in the adjacent lysine market with 520,000 tonnes of global capacity and a 9.6 percent share, on which it recorded lysine revenues of USD 269 million in 2025. Ajinomoto Co., Inc. holds a long-established amino acid position built on the fermentation technology its human food business shares. Enzymes sit at the opposite end of the spectrum, and Novonesis bought dsm-firmenich's feed enzyme activities for EUR 1.5 billion in 2025, placing them alongside enzymes developed for detergents, baking and biofuel. Cargill, Incorporated competes differently again, holding animal nutrition production and premix blending alongside its own compound feed business, which lets it capture value at more than one stage. The structural development that defines the current period is dsm-firmenich's exit. Having announced the separation of its Animal Nutrition and Health business in February 2024, it agreed to sell the remainder to CVC Capital Partners at an enterprise value of approximately EUR 2.2 billion, including an earnout of up to EUR 0.5 billion, retaining 20 percent. That business carried about EUR 3.5 billion of annual net sales and roughly EUR 0.5 billion of adjusted EBITDA in 2025, making it the largest single animal nutrition portfolio in the industry. A valuation below one times sales for a business of that quality indicates how the market prices nutrient earnings when amino acid capacity is running ahead of demand.
Major Players
Leading companies in the market
Industry Developments
7 recorded developments
Novonesis acquired the Feed Enzymes activities of dsm-firmenich for EUR 1.5 billion during 2025. The transaction consolidated feed enzyme technology with a company whose core business is industrial biotechnology rather than animal nutrition ingredients generally.
dsm-firmenich agreed to divest the remainder of its Animal Nutrition and Health business to CVC Capital Partners at an enterprise value of approximately EUR 2.2 billion, including an earnout of up to EUR 0.5 billion, while retaining a 20 percent equity stake. The unit contributed around EUR 0.5 billion of the group's adjusted EBITDA in 2025.
CJ CheilJedang Corporation recorded lysine revenues of USD 269 million for 2025 against a 9.6 percent share of that amino acid market, operating global production facilities with combined capacity of 520,000 tonnes a year.
Leading amino acid manufacturers collectively added 340,000 tonnes of annual production capacity since 2023. Capacity added faster than demand pushes amino acid prices towards cash cost, which is the mechanism that has repeatedly compressed margins in this part of animal nutrition.
Synthetic sources accounted for 73.9 percent of feed additive supply in 2025, with amino acids holding a 19.5 percent revenue share of the additives market. Asia Pacific took 35.0 percent of global feed additive revenue, the largest regional share.
Evonik Industries AG completed an expansion of DL-methionine production in Singapore, adding 40,000 tonnes to bring that site to 340,000 tonnes a year. Global capacity for its MetAMINO product reached more than 700,000 tonnes annually, and the company marked 50 years of methionine production at Antwerp in October 2024.
dsm-firmenich announced in February 2024 that it would separate its Animal Nutrition and Health business from the group. The decision put the largest single animal nutrition portfolio in the industry, representing about EUR 3.5 billion of annual net sales, into play.
Table of Contents
13 comprehensive chapters
1.1 Market Definition
1.2 Scope of the Study
1.3 Research Objectives
2.1 Research Approach
2.2 Data Sources
2.3 Market Estimation Approach
2.4 Forecast Assumptions
2.5 Research Limitations
3.1 Market Overview
3.2 Market Size and Forecast
3.3 Key Findings
3.4 Market Structure
4.1 Market Drivers
4.2 Market Challenges
4.3 Market Opportunities
4.4 Market Trends and Insights
5.1 Market Segmentation Overview
5.2 By Product Type
5.3 By Application
5.4 By Distribution Channel
5.5 By Ingredient Type
6.1 Asia Pacific
6.2 North America
6.3 Latin America
6.4 Europe
6.5 Middle East & Africa
6.6 Regional Market Comparison
7.1 Industry Developments
7.2 Industry Timeline
8.1 Market Structure and Competitive Positioning
8.2 Major Players
8.3 Strategic Developments
8.4 Key Competitive Factors
9.1 Evonik Industries AG
9.2 Novonesis A/S
9.3 Cargill, Incorporated
9.4 CJ CheilJedang Corporation
9.5 Ajinomoto Co., Inc.
10.1 Market Size and Growth Outlook
10.2 Regional Market Outlook
10.3 Future Market Trends
10.4 Key Risks to the Forecast
11.1 Growth Opportunities
11.2 Key Risks and Constraints
11.3 Strategic Considerations
13.1 Glossary of Terms
13.2 Abbreviations
13.3 Research References
Scope of the Report
Report coverage and methodology
Study Period
Base Year: 2025
Forecast Period: 2025 - 2033
Geographic Scope
Asia Pacific, North America, Latin America, Europe, Middle East & Africa
Companies Covered
Evonik Industries AG, Novonesis A/S, Cargill, Incorporated, CJ CheilJedang Corporation + more
Data Sources
Primary research, industry interviews, regulatory filings, company reports
Frequently Asked Questions
Common questions about this report
Ready to Get the Full Report?
Access comprehensive market insights, detailed analysis, and strategic recommendations to make informed business decisions.